-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UC/XMjfP8rF00B5eK2jlkRCJaHE4OTZfV8Z/Ha2cAl16wbewdVWXebyNWMAwTHzH v1zKxvvLVK/RNTXUTyMN/w== 0001424411-09-000035.txt : 20090303 0001424411-09-000035.hdr.sgml : 20090303 20090303213529 ACCESSION NUMBER: 0001424411-09-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090302 FILED AS OF DATE: 20090303 DATE AS OF CHANGE: 20090303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saxton Mark CENTRAL INDEX KEY: 0001396243 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50988 FILM NUMBER: 09653719 BUSINESS ADDRESS: BUSINESS PHONE: (408) 360-7200 MAIL ADDRESS: STREET 1: C/O VNUS MEDICAL TECHNOLOGIES, INC. STREET 2: 5799 FONTANOSO WAY CITY: SAN JOSE STATE: CA ZIP: 95138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VNUS MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0001040666 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943216535 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5799 FONTANOSO WAY CITY: SAN JOSE STATE: CA ZIP: 95138-1015 BUSINESS PHONE: 408-360-7200 MAIL ADDRESS: STREET 1: 5799 FONTANOSO WAY CITY: SAN JOSE STATE: CA ZIP: 95138-1015 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-03-02 0 0001040666 VNUS MEDICAL TECHNOLOGIES INC VNUS 0001396243 Saxton Mark C/O VNUS MEDICAL TECHNOLOGIES, INC. 5799 FONTANOSO WAY SAN JOSE CA 95138 0 1 0 0 VP, U.S. Sales Common Stock 2009-03-02 4 M 0 21 12 A 17361 D Common Stock 2009-03-02 4 M 0 979 11.18 A 18340 D Common Stock 2009-03-02 4 S 0 1000 18.5497 D 17340 D Common Stock 2009-03-03 4 M 0 1250 0 A 18590 D Common Stock 2009-03-03 4 F 0 408 17.98 D 18182 D Incentive Stock Option (right to buy) 12 2009-03-02 4 M 0 21 0 D 2015-02-28 Common Stock 21 0 D Incentive Stock Option (right to buy) 11.18 2009-03-02 4 M 0 979 0 D 2015-05-12 Common Stock 979 4832 D Restricted Stock Units 2009-03-03 4 M 0 1250 0 D Common Stock 1250 3750 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades in prices ranging from $18.30 to $18.76. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The shares subject to the option vest and become exercisable in 48 successive and equal monthly installments measured from February 28, 2005. The shares subject to the option vest and become exercisable in 48 successive and equal monthly installments measured from May 12, 2005. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit. The restricted stock units vest in four (4) successive and equal annual installments measured from March 3, 2008, such that 100% of the restricted stock units will be fully vested on March 3, 2012. /s/ Cindee Van Vleck, Attorney-in-Fact for Mark Saxton 2009-03-03 -----END PRIVACY-ENHANCED MESSAGE-----